Cargando…

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

The immune system has many sophisticated mechanisms to balance an extensive immune response. Distinct immunosuppressive cells could protect from excessive tissue damage and autoimmune disorders. Tumor cells take an advantage of those immunosuppressive mechanisms and establish a strongly immunosuppre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleming, Viktor, Hu, Xiaoying, Weber, Rebekka, Nagibin, Vasyl, Groth, Christopher, Altevogt, Peter, Utikal, Jochen, Umansky, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840207/ https://www.ncbi.nlm.nih.gov/pubmed/29552012 http://dx.doi.org/10.3389/fimmu.2018.00398

Ejemplares similares

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
por: Arkhypov, Ihor, et al.
Publicado: (2020)

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
por: Arkhypov, Ihor, et al.
Publicado: (2022)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
por: Petrova, Vera, et al.
Publicado: (2023)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
por: Sevko, Alexandra, et al.
Publicado: (2012)

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
por: Baert, Thaïs, et al.
Publicado: (2019)

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
por: Yan, Dehong, et al.
Publicado: (2019)

TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host
por: Song, Ge, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy
por: Iglesias-Escudero, María, et al.
Publicado: (2022)

New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironment
por: Umansky, Viktor
Publicado: (2012)

Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
por: Jiang, Mengmeng, et al.
Publicado: (2017)

Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
por: Pawelec, Graham, et al.
Publicado: (2019)

Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
por: Simon, Sonja C. S., et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
por: Okła, Karolina, et al.
Publicado: (2019)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

The Yin and Yang of Myeloid Derived Suppressor Cells
por: Budhwar, Snehil, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells in Lung Transplantation
por: Heigl, Tobias, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Colorectal Cancer
por: Sieminska, Izabela, et al.
Publicado: (2020)

Myeloid-derived suppressor cells and pulmonary hypertension
por: Zhang, Hui, et al.
Publicado: (2023)

TGF-β Enhances Immunosuppression of Myeloid-Derived Suppressor Cells to Induce Transplant Immune Tolerance Through Affecting Arg-1 Expression
por: Cao, Peng, et al.
Publicado: (2022)

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
por: Lepper, Alisa, et al.
Publicado: (2023)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021)

The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment
por: Chouaib, Salem, et al.
Publicado: (2018)

The Role of Myeloid-Derived Suppressor Cells in Immune Ontogeny
por: Gantt, Soren, et al.
Publicado: (2014)

Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
por: Dorhoi, Anca, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019)

The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis
por: Magcwebeba, Tandeka, et al.
Publicado: (2019)

Myeloid-Derived Suppressor Cells in Pregnancy and the Neonatal Period
por: Köstlin-Gille, Natascha, et al.
Publicado: (2020)

Editorial: Myeloid Derived Suppressor Cells as Disease Modulators
por: Finn, Olivera J., et al.
Publicado: (2020)

Granulocytic Myeloid-Derived Suppressor Cells in Cystic Fibrosis
por: Tucker, Samantha L., et al.
Publicado: (2021)

The role of myeloid derived suppressor cells in musculoskeletal disorders
por: Ren, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7tq4l0mq4b5e3to3ulo5n6i8gi